Quest Diagnostics Incorporated (DGX) has seen noteworthy growth recently. Multiple asset management companies have increased their stake in DGX, including Assenagon Asset Management, Miracle Mile Advisors, and Oak Thistle. Earning expectations are optimistic, amid projections of strong quarterly performance. Promising industry outlooks have been provided by Zacks and other research bodies for DGX's future finances.
DGX's leadership team has been strengthened with key appointments, including Adrienne Brott as Senior Vice President and Chief Quality and Regulatory Affairs Officer. Despite being undervalued by some interpretations, DGX has instilled confidence by beating earning estimates and consistently overperforming. Several strategic acquisitions have been completed by Quest Diagnostics, enhancing diagnostic services for customers and injecting innovation in the diagnostic sphere.
Quest Health has launched health coaching on their platform, empowering individuals to take control of their health. The company has consistently been recognised for disability inclusion. Having acquired Select PathAI Diagnostics' lab assets, adoption of AI in digital pathology is expected to speed up diagnosis procedures.
Quest Diagnostics DGX News Analytics from Mon, 22 Apr 2024 07:00:00 GMT to Sat, 18 Jan 2025 11:20:35 GMT -
Rating 8
- Innovation 7
- Information 7
- Rumor 2
